Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

4-1BB enhancement of CAR T function requires NF-κB and TRAFs.

Li G, Boucher JC, Kotani H, Park K, Zhang Y, Shrestha B, Wang X, Guan L, Beatty N, Abate-Daga D, Davila ML.

JCI Insight. 2018 Sep 20;3(18). pii: 121322. doi: 10.1172/jci.insight.121322. eCollection 2018 Sep 20.

2.

The eIF2α Kinase Heme-Regulated Inhibitor Protects the Host from Infection by Regulating Intracellular Pathogen Trafficking.

Bahnan W, Boucher JC, Gayle P, Shrestha N, Rosen M, Aktas B, Adkins B, Ager A, Khan WN, Schesser K.

Infect Immun. 2018 Feb 20;86(3). pii: e00707-17. doi: 10.1128/IAI.00707-17. Print 2018 Mar.

3.

B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Khan WN, Wright JA, Kleiman E, Boucher JC, Castro I, Clark ES.

Immunol Res. 2013 Dec;57(1-3):335-53. doi: 10.1007/s12026-013-8466-z. Review.

PMID:
24293007
4.

The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model.

Fullner KJ, Boucher JC, Hanes MA, Haines GK 3rd, Meehan BM, Walchle C, Sansonetti PJ, Mekalanos JJ.

J Exp Med. 2002 Jun 3;195(11):1455-62.

5.

Hyperacidification of cellubrevin endocytic compartments and defective endosomal recycling in cystic fibrosis respiratory epithelial cells.

Poschet JF, Skidmore J, Boucher JC, Firoved AM, Van Dyke RW, Deretic V.

J Biol Chem. 2002 Apr 19;277(16):13959-65. Epub 2002 Jan 24.

7.

Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.

Poschet JF, Boucher JC, Tatterson L, Skidmore J, Van Dyke RW, Deretic V.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13972-7.

8.

Conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.

Poschet JF, Boucher JC, Firoved AM, Deretic V.

Methods Enzymol. 2001;336:65-76. No abstract available.

PMID:
11398420
9.

Dual regulation of mucoidy in Pseudomonas aeruginosa and sigma factor antagonism.

Boucher JC, Schurr MJ, Deretic V.

Mol Microbiol. 2000 Apr;36(2):341-51.

11.

Pseudomonas aeruginosa in cystic fibrosis: role of mucC in the regulation of alginate production and stress sensitivity.

Boucher JC, Schurr MJ, Yu H, Rowen DW, Deretic V.

Microbiology. 1997 Nov;143 ( Pt 11):3473-80.

PMID:
9387225
15.

Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE).

Yu H, Boucher JC, Hibler NS, Deretic V.

Infect Immun. 1996 Jul;64(7):2774-81.

16.
17.

Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA.

Boucher JC, Martinez-Salazar J, Schurr MJ, Mudd MH, Yu H, Deretic V.

J Bacteriol. 1996 Jan;178(2):511-23.

19.

Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors.

Deretic V, Schurr MJ, Boucher JC, Martin DW.

J Bacteriol. 1994 May;176(10):2773-80. Review. No abstract available.

20.

Conversion to mucoidy in Pseudomonas aeruginosa.

Deretic V, Martin DW, Schurr MJ, Mudd MH, Hibler NS, Curcic R, Boucher JC.

Biotechnology (N Y). 1993 Oct;11(10):1133-6. Review.

PMID:
7764093
21.

The algD promoter: regulation of alginate production by Pseudomonas aeruginosa in cystic fibrosis.

Schurr MJ, Martin DW, Mudd MH, Hibler NS, Boucher JC, Deretic V.

Cell Mol Biol Res. 1993;39(4):371-6. Review.

PMID:
8312973

Supplemental Content

Loading ...
Support Center